SIMVASTATIN for Atrial fibrillation: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 42 adverse event reports in the FDA FAERS database where SIMVASTATIN was used for Atrial fibrillation.
Most Reported Side Effects for SIMVASTATIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myalgia | 3,919 | 14.5% | 252 | 422 |
| Fatigue | 2,066 | 7.6% | 226 | 424 |
| Arthralgia | 1,775 | 6.6% | 221 | 318 |
| Drug interaction | 1,744 | 6.4% | 221 | 1,037 |
| Nausea | 1,676 | 6.2% | 481 | 635 |
| Rhabdomyolysis | 1,616 | 6.0% | 148 | 1,232 |
| Dyspnoea | 1,542 | 5.7% | 340 | 604 |
| Headache | 1,470 | 5.4% | 224 | 431 |
| Drug hypersensitivity | 1,433 | 5.3% | 125 | 171 |
| Muscular weakness | 1,356 | 5.0% | 19 | 362 |
| Malaise | 1,347 | 5.0% | 218 | 512 |
| Dizziness | 1,334 | 4.9% | 257 | 323 |
| Vomiting | 1,318 | 4.9% | 443 | 484 |
| Diarrhoea | 1,310 | 4.8% | 276 | 406 |
| Pain | 1,283 | 4.7% | 30 | 460 |
Other Indications for SIMVASTATIN
Product used for unknown indication (9,405)
Hypercholesterolaemia (3,010)
Blood cholesterol increased (2,592)
Hyperlipidaemia (1,320)
Dyslipidaemia (1,253)
Blood cholesterol (419)
Coronary artery disease (407)
Blood cholesterol abnormal (371)
Type iia hyperlipidaemia (294)
Low density lipoprotein increased (237)
Other Drugs Used for Atrial fibrillation
RIVAROXABAN (52,584)
DABIGATRAN ETEXILATE (20,492)
APIXABAN (10,500)
AMIODARONE (9,083)
WARFARIN (8,680)
EDOXABAN (3,855)
ASPIRIN (2,993)
DOFETILIDE (2,439)
PRADAXA (2,325)
METOPROLOL (1,542)